Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHEK NASDAQ:QNRX OTCMKTS:UMGP OTCMKTS:YBGJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEKCheck-Cap$0.67-1.7%$0.74$0.56▼$3.04$3.89M0.1927,084 shs11,325 shsQNRXQuoin Pharmaceuticals$7.48+2.5%$8.32$5.01▼$54.95$4.40M1.444,234 shs4,358 shsUMGPDalton Industries$0.02$0.03$0.02▼$0.16$910K0.136,447 shs10,329 shsYBGJYubo International Biotech$0.03$0.07$0.03▼$0.54$3.91M3.74241,359 shsN/AElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEKCheck-Cap0.00%-0.73%-13.64%-28.12%-64.53%QNRXQuoin Pharmaceuticals0.00%+5.20%-14.42%-2.86%-55.64%UMGPDalton Industries0.00%-17.67%-6.79%-37.63%-81.00%YBGJYubo International Biotech0.00%-9.33%-70.94%-57.73%-82.87%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEKCheck-Cap0.4136 of 5 stars0.03.00.00.01.90.00.6QNRXQuoin Pharmaceuticals1.257 of 5 stars0.04.00.00.03.30.80.6UMGPDalton IndustriesN/AN/AN/AN/AN/AN/AN/AN/AYBGJYubo International Biotech0.3288 of 5 stars0.03.00.00.01.01.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEKCheck-Cap 0.00N/AN/AN/AQNRXQuoin Pharmaceuticals 0.00N/AN/AN/AUMGPDalton Industries 0.00N/AN/AN/AYBGJYubo International Biotech 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEKCheck-CapN/AN/AN/AN/A$4.05 per shareN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/A$4.34 per shareN/AUMGPDalton Industries$30K30.30N/AN/AN/A∞YBGJYubo International BiotechN/AN/AN/AN/A($0.03) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEKCheck-Cap-$17.57M-$3.00N/A∞N/AN/AN/AN/AN/AQNRXQuoin Pharmaceuticals-$8.96M-$41.45N/AN/AN/AN/A-210.50%-99.41%N/AUMGPDalton Industries-$260K-$0.01N/A∞N/AN/AN/AN/AN/AYBGJYubo International Biotech-$1.77M-$0.01N/A∞N/AN/AN/A-118.36%N/ALatest UMGP, YBGJ, QNRX, and CHEK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025QNRXQuoin Pharmaceuticals-$6.83-$6.28+$0.55-$6.28N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEKCheck-CapN/AN/AN/AN/AN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/AYBGJYubo International BiotechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEKCheck-CapN/AN/AN/AQNRXQuoin PharmaceuticalsN/A1.961.96UMGPDalton IndustriesN/AN/AN/AYBGJYubo International BiotechN/A0.130.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEKCheck-Cap1.07%QNRXQuoin Pharmaceuticals8.63%UMGPDalton IndustriesN/AYBGJYubo International BiotechN/AInsider OwnershipCompanyInsider OwnershipCHEKCheck-Cap0.48%QNRXQuoin Pharmaceuticals13.46%UMGPDalton IndustriesN/AYBGJYubo International Biotech68.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEKCheck-Cap805.85 million5.82 millionNot OptionableQNRXQuoin Pharmaceuticals4588,000509,000Not OptionableUMGPDalton Industries2436.80 millionN/ANot OptionableYBGJYubo International Biotech20119.82 million37.74 millionNot OptionableUMGP, YBGJ, QNRX, and CHEK HeadlinesRecent News About These CompaniesShort Interest in Yubo International Biotech Limited (OTCMKTS:YBGJ) Rises By 40,000.0%August 16 at 2:45 AM | americanbankingnews.comYubo International Biotech Limited (YBGJ)March 21, 2025 | finance.yahoo.comYubo International Biotech LimitedNovember 21, 2024 | investing.comYBGJ Yubo International Biotech LimitedMay 24, 2024 | seekingalpha.comForever Cheer picks Hong Kong as gateway for global launch of pain management drugs with an eye on US$88.2 billion marketJanuary 3, 2024 | scmp.comPromontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer ClusterOctober 1, 2023 | finance.yahoo.comSABAH OFFERS TREASURE TROVE OF GENETIC RESOURCES FOR BIOTECH - MINISTERSeptember 10, 2023 | bernama.comBAs biotech conference arrives in Boston, Wu launches push to diversify industryJuly 6, 2023 | wgbh.orgWYubo International Biotech Ltd.June 15, 2023 | wsj.comChemical Engineering (Biotechnology) MEApril 20, 2023 | buffalo.eduBBiotechnology – A Solution to Hunger?February 12, 2023 | un.orgUCovid-19: Bharat Biotech to launch intranasal vaccine on January 26January 23, 2023 | scroll.inSGLOBAL TOTAL REWARDS AND INTERNATIONAL MOBILITY HEADDecember 25, 2022 | mypharma-editions.comMBiology newsSeptember 14, 2022 | phys.orgPBiotechnology Act to Crash Cost of Vaccines, Drugs Import, Drive ResearchSeptember 12, 2022 | thisdaylive.comTYubo International (OTC:YBGJ), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comYubo International (OTC:YBGJ), Analyst Ratings, Price Targets, PredictionsJuly 18, 2022 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUMGP, YBGJ, QNRX, and CHEK Company DescriptionsCheck-Cap NASDAQ:CHEK$0.66 -0.01 (-1.70%) Closing price 08/15/2025 03:59 PM EasternExtended Trading$0.65 -0.01 (-1.65%) As of 08/15/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.Quoin Pharmaceuticals NASDAQ:QNRX$7.48 +0.18 (+2.47%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$7.45 -0.03 (-0.40%) As of 08/15/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.Dalton Industries OTCMKTS:UMGP$0.02 0.00 (0.00%) As of 08/15/2025 03:06 PM EasternUniversal Media Group Inc., a media company, produces and distributes media content worldwide. It produces On The Mike, a TV show that primarily include celebrity interviews, music concerts, and other events. The company was formerly known as Dalton Industries Inc. and changed its name to Universal Media Group Inc. in January 2016. Universal Media Group Inc. was founded in 1971 and is based in Boca Raton, Florida.Yubo International Biotech OTCMKTS:YBGJ$0.03 0.00 (0.00%) As of 08/15/2025Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy Is Reddit Stock Too Hot, or Just Right? Buffett’s Mystery Buy Revealed, and It’s a Big Bet on UNH AI Glasses to Replace Smartphones? Meta Is Taking Aim at Apple Deere’s Sell-Off Could Be a Long-Term Buying Chance 3 Restaurant Stocks That Will Outperform in Q3 and Q4 Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access